Golden State Equity Partners Abbott Laboratories Transaction History
Golden State Equity Partners
- $510 Million
- Q4 2024
A detailed history of Golden State Equity Partners transactions in Abbott Laboratories stock. As of the latest transaction made, Golden State Equity Partners holds 4,880 shares of ABT stock, worth $618,686. This represents 0.11% of its overall portfolio holdings.
Number of Shares
4,880
Previous 688
609.3%
Holding current value
$618,686
Previous $78,000
606.41%
% of portfolio
0.11%
Previous 0.04%
Shares
11 transactions
Others Institutions Holding ABT
# of Institutions
3,378Shares Held
1.36BCall Options Held
10.6MPut Options Held
8.72M-
Vanguard Group Inc Valley Forge, PA169MShares$21.4 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY131MShares$16.6 Billion0.31% of portfolio
-
State Street Corp Boston, MA77.2MShares$9.78 Billion0.35% of portfolio
-
Capital International Investors Los Angeles, CA68MShares$8.62 Billion1.51% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.1MShares$6.86 Billion1.31% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $222B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...